Видео с ютуба Sacituzumab

Real-World Use Patterns, Effectiveness, & Tolerability of Sacituzumab Govitecan With Kevin Kalinsky

Sacituzumab govitecan helps some patients with PD-L1 triple-negative breast cancer live longer w...

ASCENT-05: sacituzumab govitecan and pembrolizumab in TNBC

Sacituzumab govitecan effective for HR+ metastatic breast cancer regardless of Trop-2 status

Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer

TRODELVY MOA VIDEO

Efficacy of sacituzumab govitecan by Trop-2 expression in patients with mUC

ASCENT: sacituzumab govitecan biomarker analysis

Study of sacituzumab govitecan for triple-negative breast cancer

Sacituzumab govitecan in the treatment of metastatic urothelial carcinoma

Phase III TROPICS-04 trial: sacituzumab govitecan vs treatment of choice in advanced mUC

Efficacy of sacituzumab govitecan in mUC by Trop-2 expression

ASCENT trial: sacituzumab govitecan for TNBC

Trodelvy: Magic Bullet for Triple Negative Breast Cancer

Oncotarget: Sacituzumab Govitecan in Triple-Negative Breast Cancer

Sacituzumab Govitecan with Platinum Chemotherapy: Antitumor Effects | Oncotarget

Dr. Isaacs Discusses Sacituzumab Govitecan in TNBC

OptiTROP-Lung04: сацитузумаб тирумотекан при немелкоклеточном раке легких с мутацией EGFR

ASCENT: A randomized Phase III study of sacituzumab govitecan vs treatment of physician’s choice

Final OS analysis of sacituzumab govitecan in TROPiCS-02